Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Daniel Pollyea

Concepts (484)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
118
2026
686
26.060
 Why?
Bridged Bicyclo Compounds, Heterocyclic
42
2026
280
10.530
 Why?
Sulfonamides
42
2026
583
9.210
 Why?
Antineoplastic Combined Chemotherapy Protocols
51
2026
1958
7.610
 Why?
Myelodysplastic Syndromes
30
2026
148
6.860
 Why?
Azacitidine
24
2026
157
6.310
 Why?
Antineoplastic Agents
26
2026
2207
3.400
 Why?
Mutation
37
2026
4071
3.030
 Why?
Isocitrate Dehydrogenase
13
2022
72
2.770
 Why?
Hematologic Neoplasms
10
2023
168
2.610
 Why?
Neoplasm, Residual
8
2026
143
2.380
 Why?
Neoplastic Stem Cells
15
2025
409
2.290
 Why?
Hematopoietic Stem Cell Transplantation
17
2024
698
2.090
 Why?
Triazines
7
2021
49
1.830
 Why?
Aminopyridines
7
2021
129
1.760
 Why?
Remission Induction
16
2026
306
1.650
 Why?
Neoplasm Recurrence, Local
6
2025
1146
1.590
 Why?
Prognosis
30
2026
4310
1.570
 Why?
Graft vs Host Disease
9
2024
278
1.560
 Why?
RNA Splicing Factors
3
2020
66
1.350
 Why?
Humans
164
2026
145140
1.340
 Why?
Aged
63
2026
26096
1.310
 Why?
Aged, 80 and over
34
2025
8318
1.300
 Why?
Phosphoproteins
3
2020
337
1.180
 Why?
Cytarabine
8
2022
66
1.160
 Why?
Treatment Outcome
35
2026
11741
1.100
 Why?
Leukemia
4
2023
246
1.050
 Why?
Immunotherapy, Adoptive
3
2025
342
0.950
 Why?
Salvage Therapy
5
2023
165
0.940
 Why?
Clonal Evolution
2
2017
47
0.930
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2025
7
0.920
 Why?
Cord Blood Stem Cell Transplantation
4
2024
103
0.910
 Why?
Middle Aged
51
2026
36126
0.890
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2022
76
0.840
 Why?
fms-Like Tyrosine Kinase 3
4
2017
51
0.830
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2023
296
0.820
 Why?
Nuclear Proteins
5
2018
738
0.820
 Why?
Histocompatibility Antigens Class I
1
2025
202
0.820
 Why?
Drug Resistance, Neoplasm
9
2025
881
0.810
 Why?
Molecular Targeted Therapy
7
2024
438
0.790
 Why?
Carrier Proteins
3
2017
728
0.780
 Why?
Transplantation Conditioning
9
2024
191
0.760
 Why?
Leukemia, Neutrophilic, Chronic
3
2019
5
0.760
 Why?
Thrombocytopenia
2
2023
204
0.730
 Why?
Spliceosomes
2
2020
54
0.730
 Why?
Dancing
1
2022
19
0.730
 Why?
Male
61
2026
72664
0.710
 Why?
Proto-Oncogene Proteins c-bcl-2
4
2018
239
0.690
 Why?
Enzyme Inhibitors
5
2020
820
0.690
 Why?
Female
66
2026
78636
0.690
 Why?
Anemia
2
2020
190
0.690
 Why?
Febrile Neutropenia
1
2020
6
0.660
 Why?
Adult
37
2025
40665
0.650
 Why?
Splicing Factor U2AF
2
2023
18
0.630
 Why?
T-Lymphocytes
2
2025
1993
0.610
 Why?
Receptors, Colony-Stimulating Factor
2
2017
7
0.610
 Why?
Serine-Arginine Splicing Factors
2
2019
27
0.600
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
2025
127
0.600
 Why?
DNA Methylation
3
2019
667
0.560
 Why?
Phenylurea Compounds
7
2020
119
0.550
 Why?
Staurosporine
1
2017
22
0.540
 Why?
Stem Cells
3
2020
624
0.530
 Why?
Benzimidazoles
6
2020
189
0.500
 Why?
Gene Frequency
2
2017
484
0.490
 Why?
Protein Kinase Inhibitors
10
2025
979
0.470
 Why?
Monocytes
2
2018
537
0.470
 Why?
Neoplasms, Plasma Cell
1
2015
5
0.470
 Why?
Recurrence
9
2023
1134
0.460
 Why?
Leukocytosis
1
2015
32
0.460
 Why?
Skin Neoplasms
1
2023
848
0.460
 Why?
Signal Transduction
10
2025
5208
0.460
 Why?
Glycine
4
2021
186
0.460
 Why?
High-Throughput Nucleotide Sequencing
2
2018
530
0.460
 Why?
Gene Expression
1
2020
1474
0.460
 Why?
Epigenesis, Genetic
1
2019
672
0.430
 Why?
Maximum Tolerated Dose
5
2019
210
0.420
 Why?
Precision Medicine
1
2018
459
0.420
 Why?
Oxidative Phosphorylation
6
2024
209
0.410
 Why?
Computational Biology
1
2019
669
0.410
 Why?
Retrospective Studies
16
2024
17247
0.410
 Why?
Patient Safety
1
2018
355
0.410
 Why?
Clinical Trials, Phase I as Topic
2
2024
50
0.400
 Why?
Apoptosis
4
2018
2434
0.400
 Why?
Induction Chemotherapy
3
2024
87
0.400
 Why?
Pyridines
5
2023
608
0.400
 Why?
Clinical Trials, Phase III as Topic
2
2024
116
0.400
 Why?
Medical Oncology
4
2023
338
0.400
 Why?
Hematopoiesis
4
2020
193
0.400
 Why?
Neoplasm Proteins
4
2022
441
0.400
 Why?
Neoplasms
5
2025
2900
0.380
 Why?
Immunity, Innate
1
2019
834
0.380
 Why?
Dose-Response Relationship, Drug
7
2021
2026
0.380
 Why?
Pyrazoles
1
2017
517
0.380
 Why?
Germ-Line Mutation
3
2022
176
0.370
 Why?
Leukemia, Myeloid
1
2012
48
0.370
 Why?
Mitochondria
4
2025
992
0.370
 Why?
Glutarates
1
2012
11
0.370
 Why?
DNA (Cytosine-5-)-Methyltransferases
2
2018
36
0.360
 Why?
STAT3 Transcription Factor
2
2025
206
0.350
 Why?
Biomarkers, Tumor
5
2025
1320
0.350
 Why?
Survival Rate
11
2025
2087
0.350
 Why?
RNA Splicing
4
2023
284
0.340
 Why?
Neutrophils
2
2023
1123
0.340
 Why?
Young Adult
16
2025
14176
0.330
 Why?
United States Food and Drug Administration
2
2022
207
0.330
 Why?
Follow-Up Studies
8
2020
5411
0.330
 Why?
Drug Delivery Systems
1
2014
380
0.330
 Why?
Aldehyde Dehydrogenase
3
2017
99
0.320
 Why?
Antibodies, Monoclonal, Humanized
7
2023
992
0.310
 Why?
Leukocyte Count
2
2024
316
0.310
 Why?
Rhipicephalus sanguineus
1
2009
1
0.310
 Why?
Triatoma
1
2009
7
0.310
 Why?
Insect Bites and Stings
1
2009
13
0.310
 Why?
Wasps
1
2009
23
0.300
 Why?
Syncope
1
2009
56
0.300
 Why?
Cytokines
4
2020
2048
0.290
 Why?
Electron Transport Complex II
2
2019
27
0.290
 Why?
Mutant Proteins
2
2019
105
0.280
 Why?
Proto-Oncogene Proteins
2
2018
623
0.280
 Why?
Kaplan-Meier Estimate
5
2020
968
0.280
 Why?
Influenza A Virus, H1N1 Subtype
1
2010
159
0.280
 Why?
Cell Self Renewal
2
2019
52
0.280
 Why?
Anaphylaxis
1
2009
102
0.280
 Why?
Acute Disease
3
2023
1035
0.270
 Why?
Administration, Oral
4
2018
862
0.270
 Why?
Risk Assessment
5
2024
3740
0.270
 Why?
Bone Marrow
4
2017
306
0.270
 Why?
Transplantation, Homologous
6
2022
417
0.270
 Why?
Survival Analysis
6
2020
1371
0.260
 Why?
Gene Expression Regulation, Leukemic
3
2016
56
0.260
 Why?
Randomized Controlled Trials as Topic
3
2024
1742
0.260
 Why?
Drug Administration Schedule
4
2020
781
0.260
 Why?
Animals
28
2026
37952
0.250
 Why?
Disease-Free Survival
5
2022
766
0.250
 Why?
Mice
20
2026
18303
0.250
 Why?
Thrombocythemia, Essential
2
2016
6
0.240
 Why?
Polycythemia Vera
2
2016
8
0.240
 Why?
Primary Myelofibrosis
2
2016
8
0.240
 Why?
Cytogenetic Analysis
2
2022
33
0.230
 Why?
Voltage-Dependent Anion Channel 1
1
2025
15
0.230
 Why?
Hematopoietic Stem Cells
3
2022
418
0.230
 Why?
Hematopoietic Cell Growth Factors
1
2025
5
0.230
 Why?
Clinical Trials as Topic
4
2020
1058
0.220
 Why?
Phenotype
3
2025
3138
0.220
 Why?
Influenza Vaccines
1
2010
534
0.220
 Why?
DEAD-box RNA Helicases
2
2015
83
0.220
 Why?
Transplantation, Haploidentical
1
2024
23
0.210
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2025
161
0.200
 Why?
Stem Cell Transplantation
3
2023
189
0.200
 Why?
Influenza, Human
1
2010
624
0.200
 Why?
Azetidines
1
2024
45
0.200
 Why?
Allografts
2
2021
151
0.200
 Why?
Finland
1
2023
78
0.200
 Why?
DNA Mutational Analysis
4
2019
407
0.190
 Why?
Time-to-Treatment
1
2025
250
0.190
 Why?
Down-Regulation
1
2025
618
0.190
 Why?
DNA-Binding Proteins
1
2010
1479
0.190
 Why?
Drug Therapy, Combination
4
2022
1043
0.190
 Why?
Antibodies, Neoplasm
3
2007
34
0.190
 Why?
Antibodies, Monoclonal
4
2017
1505
0.190
 Why?
Disease Management
4
2021
651
0.190
 Why?
Uncertainty
1
2023
145
0.180
 Why?
Interleukin-3 Receptor alpha Subunit
2
2019
17
0.180
 Why?
RNA, Messenger
1
2010
2803
0.180
 Why?
Piperidines
1
2024
220
0.180
 Why?
Myeloproliferative Disorders
1
2022
21
0.180
 Why?
Hematology
1
2022
21
0.180
 Why?
Amino Acid Transport System ASC
1
2022
12
0.180
 Why?
Thalidomide
2
2012
43
0.180
 Why?
Proto-Oncogene Proteins c-myc
2
2022
167
0.180
 Why?
Succinate Dehydrogenase
2
2019
65
0.170
 Why?
Minor Histocompatibility Antigens
1
2022
47
0.170
 Why?
Lymphoma, Non-Hodgkin
1
2023
124
0.170
 Why?
Calcium
2
2025
1189
0.170
 Why?
Disease Progression
3
2023
2857
0.170
 Why?
Receptors, Mitogen
1
2021
7
0.170
 Why?
Cell Line, Tumor
8
2025
3539
0.170
 Why?
Polymerase Chain Reaction
1
2024
1039
0.170
 Why?
Lectins, C-Type
1
2021
59
0.170
 Why?
Blood Cell Count
1
2020
55
0.160
 Why?
Erythroblasts
1
2020
18
0.160
 Why?
Lipids
1
2025
706
0.160
 Why?
Cell Transformation, Neoplastic
3
2018
337
0.160
 Why?
Inflammation Mediators
2
2020
506
0.160
 Why?
Histocompatibility Testing
2
2019
123
0.160
 Why?
Lipase
1
2020
75
0.160
 Why?
Tumor Lysis Syndrome
1
2019
9
0.150
 Why?
United States
6
2025
16065
0.150
 Why?
Cell Survival
5
2025
1100
0.150
 Why?
Dendritic Cells
1
2023
496
0.150
 Why?
Chemical and Drug Induced Liver Injury
1
2021
138
0.150
 Why?
Leukopoiesis
1
2019
11
0.150
 Why?
Immunoconjugates
1
2021
138
0.150
 Why?
NADPH Oxidase 2
1
2019
32
0.150
 Why?
Myeloid Progenitor Cells
1
2019
16
0.150
 Why?
NF-kappa B p50 Subunit
1
2019
23
0.150
 Why?
RAW 264.7 Cells
1
2019
48
0.140
 Why?
K562 Cells
1
2019
92
0.140
 Why?
Age Factors
5
2022
3338
0.140
 Why?
Tricarboxylic Acids
1
2018
11
0.140
 Why?
Fatty Acids
2
2020
457
0.140
 Why?
Genetic Testing
2
2019
480
0.140
 Why?
Ketoglutaric Acids
1
2018
22
0.140
 Why?
Hematologic Diseases
1
2019
66
0.140
 Why?
Mycoses
1
2019
88
0.140
 Why?
Genomics
3
2019
819
0.140
 Why?
Antibodies
1
2021
397
0.140
 Why?
Tumor Suppressor Protein p53
1
2022
532
0.140
 Why?
Mitochondrial Proteins
2
2018
263
0.140
 Why?
Macrophages
1
2026
1500
0.140
 Why?
Thiotepa
1
2018
21
0.140
 Why?
Trees
1
2018
59
0.140
 Why?
Antimetabolites, Antineoplastic
1
2018
105
0.140
 Why?
Antibiotic Prophylaxis
1
2019
134
0.140
 Why?
Amino Acids
2
2020
519
0.140
 Why?
Cysteine
1
2019
210
0.130
 Why?
Lymphoma
2
2017
233
0.130
 Why?
Fusion Proteins, bcr-abl
2
2014
68
0.130
 Why?
HLA-DR Antigens
1
2018
220
0.130
 Why?
Confidence Intervals
1
2018
330
0.130
 Why?
Hematinics
1
2017
22
0.130
 Why?
Mediastinal Neoplasms
1
2017
53
0.120
 Why?
AMP-Activated Protein Kinases
1
2018
192
0.120
 Why?
Infusions, Intravenous
1
2018
428
0.120
 Why?
Hedgehog Proteins
1
2018
200
0.120
 Why?
Periodicals as Topic
1
2019
209
0.120
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
68
0.120
 Why?
Unrelated Donors
1
2016
39
0.120
 Why?
Registries
3
2025
2401
0.120
 Why?
Genome, Human
1
2018
419
0.120
 Why?
Cohort Studies
5
2022
5988
0.120
 Why?
Glucosephosphate Dehydrogenase
1
2016
70
0.120
 Why?
Pyrimidines
2
2017
530
0.120
 Why?
Geriatric Assessment
1
2018
238
0.120
 Why?
Energy Metabolism
2
2019
933
0.120
 Why?
Oncogene Proteins
1
2016
61
0.110
 Why?
NF-E2-Related Factor 2
1
2016
101
0.110
 Why?
Nitriles
1
2017
207
0.110
 Why?
Receptor-Interacting Protein Serine-Threonine Kinases
1
2015
14
0.110
 Why?
Genetic Predisposition to Disease
2
2022
2351
0.110
 Why?
Mice, Inbred NOD
4
2019
613
0.110
 Why?
Methyltransferases
1
2016
75
0.110
 Why?
Lipopolysaccharides
1
2019
858
0.110
 Why?
Myeloid-Lymphoid Leukemia Protein
1
2016
72
0.110
 Why?
Biomarkers
3
2022
4282
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
264
0.110
 Why?
Oligomycins
1
2014
7
0.110
 Why?
Chromosome Aberrations
1
2015
165
0.110
 Why?
Hemoglobins
2
2018
386
0.110
 Why?
Mitochondrial Proton-Translocating ATPases
1
2014
23
0.110
 Why?
Adolescent
7
2024
22479
0.110
 Why?
In Situ Hybridization, Fluorescence
1
2015
323
0.110
 Why?
Electronic Health Records
1
2023
1188
0.110
 Why?
Homeostasis
1
2018
639
0.110
 Why?
Calcineurin Inhibitors
1
2014
69
0.100
 Why?
Necrosis
1
2015
243
0.100
 Why?
Histone-Lysine N-Methyltransferase
1
2016
141
0.100
 Why?
Cells, Cultured
5
2019
4142
0.100
 Why?
Vidarabine
2
2018
32
0.100
 Why?
Harringtonines
1
2013
2
0.100
 Why?
Tumor Suppressor Proteins
1
2016
320
0.100
 Why?
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
2013
1
0.100
 Why?
Predictive Value of Tests
1
2019
2115
0.100
 Why?
Alemtuzumab
3
2007
15
0.100
 Why?
Gene Expression Profiling
3
2019
1763
0.100
 Why?
Interleukin-1
1
2017
961
0.100
 Why?
Glucose
1
2018
1048
0.100
 Why?
Pyridazines
1
2013
57
0.090
 Why?
Carbon Monoxide
1
2013
82
0.090
 Why?
Gene Expression Regulation, Neoplastic
1
2018
1442
0.090
 Why?
Nausea
1
2012
112
0.090
 Why?
5-Methylcytosine
1
2012
24
0.090
 Why?
Biopsy
1
2015
1079
0.090
 Why?
Vomiting
1
2012
131
0.090
 Why?
Liver
1
2020
1893
0.090
 Why?
Imidazoles
1
2013
247
0.090
 Why?
Membrane Proteins
1
2018
1163
0.090
 Why?
Core Binding Factor Alpha 2 Subunit
2
2023
30
0.080
 Why?
Incidence
2
2016
2915
0.080
 Why?
Amino Acid Sequence
2
2015
2127
0.080
 Why?
Dioxygenases
1
2010
34
0.080
 Why?
Sesquiterpenes
2
2016
52
0.080
 Why?
Oxidants
1
2011
99
0.080
 Why?
Fatigue
1
2012
363
0.080
 Why?
Software
1
2015
678
0.080
 Why?
GTP-Binding Proteins
1
2011
153
0.080
 Why?
Length of Stay
1
2016
1348
0.080
 Why?
Chronic Disease
1
2016
1806
0.080
 Why?
Wasp Venoms
1
2009
4
0.080
 Why?
Insulin Resistance
1
2018
1244
0.080
 Why?
Ethanol
1
2015
631
0.080
 Why?
Blast Crisis
2
2025
34
0.080
 Why?
Protein Multimerization
1
2011
204
0.080
 Why?
Injections, Subcutaneous
1
2009
170
0.070
 Why?
Hydrogen Peroxide
1
2011
335
0.070
 Why?
Epinephrine
1
2009
158
0.070
 Why?
Mice, Transgenic
3
2023
2185
0.070
 Why?
Immunization Schedule
1
2010
186
0.070
 Why?
Emergencies
1
2009
174
0.070
 Why?
Adjuvants, Immunologic
1
2010
243
0.070
 Why?
RNA, Small Interfering
3
2016
634
0.070
 Why?
Melphalan
1
2007
43
0.070
 Why?
Inflammation
1
2019
2876
0.060
 Why?
Phosphorylation
2
2025
1706
0.060
 Why?
Tumor Cells, Cultured
2
2022
886
0.060
 Why?
Transplantation Chimera
1
2007
57
0.060
 Why?
Karnofsky Performance Status
1
2006
37
0.060
 Why?
Blood Transfusion
2
2020
407
0.060
 Why?
HEK293 Cells
2
2019
740
0.060
 Why?
Cell Differentiation
2
2026
2040
0.060
 Why?
Disease Models, Animal
3
2026
4552
0.060
 Why?
Protein-Tyrosine Kinases
3
2014
431
0.060
 Why?
Mice, Inbred C57BL
4
2020
5972
0.060
 Why?
Receptors, Thrombopoietin
2
2016
6
0.060
 Why?
Calreticulin
2
2016
22
0.060
 Why?
Janus Kinase 2
2
2016
29
0.060
 Why?
Evidence-Based Medicine
1
2010
739
0.060
 Why?
Exome
2
2018
227
0.060
 Why?
Ganciclovir
1
2006
53
0.060
 Why?
Valine
1
2006
82
0.060
 Why?
Acyclovir
1
2006
97
0.060
 Why?
Philadelphia Chromosome
2
2016
18
0.060
 Why?
Cell Proliferation
3
2020
2504
0.050
 Why?
Granulocyte Colony-Stimulating Factor
1
2025
90
0.050
 Why?
Risk Factors
3
2014
10857
0.050
 Why?
Phagocytosis
1
2026
296
0.050
 Why?
Bone Marrow Transplantation
1
2006
297
0.050
 Why?
Pedigree
2
2015
515
0.050
 Why?
Janus Kinases
2
2015
21
0.050
 Why?
Oxidation-Reduction
2
2019
1066
0.050
 Why?
Cytomegalovirus Infections
1
2006
206
0.050
 Why?
Diamines
1
2023
5
0.050
 Why?
Antigens, CD34
1
2023
89
0.050
 Why?
para-Aminobenzoates
1
2023
8
0.050
 Why?
Chemotaxis
1
2023
122
0.050
 Why?
Xenograft Model Antitumor Assays
2
2016
932
0.050
 Why?
Flow Cytometry
2
2018
1159
0.050
 Why?
Aniline Compounds
1
2023
120
0.050
 Why?
Breast Neoplasms
1
2015
2380
0.040
 Why?
Angiogenesis Inhibitors
1
2004
238
0.040
 Why?
Pyrrolidines
1
2023
125
0.040
 Why?
Practice Guidelines as Topic
1
2010
1579
0.040
 Why?
Neutropenia
1
2022
154
0.040
 Why?
Drug Interactions
2
2013
404
0.040
 Why?
Recombinant Proteins
1
2025
1368
0.040
 Why?
Benzodiazepines
1
2023
168
0.040
 Why?
Early Termination of Clinical Trials
1
2021
18
0.040
 Why?
Quinuclidines
1
2020
11
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
75
0.040
 Why?
Hyperbilirubinemia
1
2020
11
0.040
 Why?
Receptors, Cell Surface
1
2022
372
0.040
 Why?
Niacinamide
1
2020
87
0.040
 Why?
Antiviral Agents
1
2006
767
0.040
 Why?
Neoplasms, Second Primary
1
2021
102
0.040
 Why?
Machine Learning
1
2025
586
0.040
 Why?
Proportional Hazards Models
2
2017
1325
0.040
 Why?
Lentivirus
1
2019
61
0.040
 Why?
Disease Susceptibility
1
2021
343
0.040
 Why?
Mice, Nude
2
2015
679
0.040
 Why?
Daunorubicin
1
2018
25
0.040
 Why?
Consolidation Chemotherapy
1
2018
11
0.040
 Why?
Maintenance Chemotherapy
1
2018
42
0.040
 Why?
Multicenter Studies as Topic
1
2020
410
0.040
 Why?
Myeloablative Agonists
1
2018
23
0.030
 Why?
Mice, SCID
1
2019
369
0.030
 Why?
Datasets as Topic
1
2018
118
0.030
 Why?
Mice, Knockout
2
2016
3114
0.030
 Why?
Iron
1
2020
357
0.030
 Why?
Fetal Blood
1
2020
325
0.030
 Why?
Forkhead Transcription Factors
1
2019
207
0.030
 Why?
Cause of Death
1
2020
470
0.030
 Why?
Whole-Body Irradiation
1
2018
74
0.030
 Why?
HLA Antigens
1
2019
238
0.030
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
17
0.030
 Why?
Cell Count
1
2018
319
0.030
 Why?
Antineoplastic Agents, Immunological
1
2020
198
0.030
 Why?
Biological Transport
1
2018
423
0.030
 Why?
Child
2
2024
22670
0.030
 Why?
Clinical Decision-Making
1
2021
362
0.030
 Why?
Tumor Stem Cell Assay
1
2017
34
0.030
 Why?
Glutathione
1
2019
370
0.030
 Why?
Combined Modality Therapy
1
2020
1264
0.030
 Why?
Retinal Dehydrogenase
1
2017
29
0.030
 Why?
Diet, High-Fat
1
2018
266
0.030
 Why?
Arsenicals
1
2017
28
0.030
 Why?
Oxides
1
2017
47
0.030
 Why?
Glycolysis
1
2018
340
0.030
 Why?
Benzothiazoles
1
2016
39
0.030
 Why?
NADP
1
2016
52
0.030
 Why?
Heterografts
1
2017
143
0.030
 Why?
Hydrazines
1
2016
37
0.030
 Why?
Adenosine Triphosphate
1
2019
499
0.030
 Why?
Cyclophosphamide
1
2017
266
0.030
 Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
1
2016
11
0.030
 Why?
Kinetics
1
2019
1567
0.030
 Why?
Drug Monitoring
1
2020
399
0.030
 Why?
Deoxyglucose
1
2016
51
0.030
 Why?
Receptors, Interleukin-1
1
2017
211
0.030
 Why?
Reactive Oxygen Species
1
2019
611
0.030
 Why?
Sample Size
1
2016
121
0.030
 Why?
Sequence Analysis, RNA
1
2018
442
0.030
 Why?
Drug Combinations
1
2017
396
0.030
 Why?
Tumor Microenvironment
1
2020
733
0.030
 Why?
p38 Mitogen-Activated Protein Kinases
1
2017
264
0.030
 Why?
Isoenzymes
1
2016
294
0.030
 Why?
Transcriptome
1
2022
1029
0.030
 Why?
Positron-Emission Tomography
1
2017
343
0.030
 Why?
Splenomegaly
1
2015
15
0.030
 Why?
Colorado
1
2025
4538
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2017
376
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2017
382
0.030
 Why?
Repressor Proteins
1
2018
429
0.030
 Why?
Dihydrolipoyllysine-Residue Acetyltransferase
1
2014
6
0.030
 Why?
Hydroxyurea
1
2015
34
0.030
 Why?
Ketone Oxidoreductases
1
2014
7
0.030
 Why?
Comorbidity
2
2013
1657
0.030
 Why?
Metabolome
1
2018
387
0.030
 Why?
Fluorescent Antibody Technique
1
2015
365
0.030
 Why?
Lipid Metabolism
1
2018
529
0.030
 Why?
Diagnosis, Differential
1
2019
1506
0.030
 Why?
Interleukin-1beta
1
2017
390
0.030
 Why?
Membrane Potential, Mitochondrial
1
2014
74
0.030
 Why?
Imatinib Mesylate
1
2014
77
0.030
 Why?
Sirolimus
1
2016
280
0.030
 Why?
Sequence Homology, Amino Acid
1
2015
387
0.030
 Why?
Health Services Accessibility
1
2023
1099
0.030
 Why?
Immunologic Factors
1
2017
260
0.030
 Why?
Superoxides
1
2014
198
0.030
 Why?
Dasatinib
1
2014
58
0.030
 Why?
Quality of Life
2
2016
3194
0.030
 Why?
Age of Onset
1
2015
554
0.030
 Why?
Structure-Activity Relationship
1
2015
563
0.030
 Why?
Genetic Heterogeneity
1
2014
65
0.020
 Why?
Research Design
1
2020
1132
0.020
 Why?
Thiazoles
1
2014
140
0.020
 Why?
Leukemia, Lymphoid
1
2013
27
0.020
 Why?
Trans-Activators
1
2016
396
0.020
 Why?
Up-Regulation
1
2016
846
0.020
 Why?
Drug Synergism
1
2014
354
0.020
 Why?
Cyclosporine
1
2014
256
0.020
 Why?
Pulmonary Diffusing Capacity
1
2013
78
0.020
 Why?
RNA Interference
1
2014
474
0.020
 Why?
Polymorphism, Single Nucleotide
1
2020
2136
0.020
 Why?
Mice, Inbred BALB C
1
2015
1261
0.020
 Why?
Homeodomain Proteins
1
2016
522
0.020
 Why?
Cost-Benefit Analysis
1
2015
640
0.020
 Why?
Leupeptins
1
2011
13
0.020
 Why?
HL-60 Cells
1
2011
30
0.020
 Why?
Respiratory Function Tests
1
2013
543
0.020
 Why?
Proteasome Inhibitors
1
2011
41
0.020
 Why?
Cysteine Proteinase Inhibitors
1
2011
49
0.020
 Why?
Thrombosis
1
2015
401
0.020
 Why?
Mitoxantrone
1
2010
15
0.020
 Why?
Free Radical Scavengers
1
2011
82
0.020
 Why?
Genotype
1
2015
1844
0.020
 Why?
Molecular Sequence Data
1
2015
2881
0.020
 Why?
Etoposide
1
2010
167
0.020
 Why?
Neoplasms, Experimental
1
2011
167
0.020
 Why?
Acetylcysteine
1
2011
139
0.020
 Why?
Mutagenesis, Site-Directed
1
2011
376
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
155
0.020
 Why?
Prospective Studies
2
2016
8035
0.020
 Why?
Models, Biological
1
2017
1763
0.020
 Why?
Treatment Failure
1
2010
360
0.020
 Why?
Prevalence
1
2016
2855
0.020
 Why?
Insulin
1
2018
2510
0.020
 Why?
RNA-Binding Proteins
1
2011
447
0.020
 Why?
Nitroimidazoles
1
2004
16
0.010
 Why?
Cyclohexanes
1
2004
22
0.010
 Why?
Fluorescein
1
2004
24
0.010
 Why?
In Situ Nick-End Labeling
1
2004
119
0.010
 Why?
Radiation-Sensitizing Agents
1
2004
43
0.010
 Why?
Lectins
1
2004
44
0.010
 Why?
Neoplasm Transplantation
1
2004
246
0.010
 Why?
In Situ Hybridization
1
2004
318
0.010
 Why?
Microcirculation
1
2004
142
0.010
 Why?
Angiography
1
2004
208
0.010
 Why?
Antibiotics, Antineoplastic
1
2004
139
0.010
 Why?
Capillaries
1
2004
125
0.010
 Why?
Wilms Tumor
1
2004
88
0.010
 Why?
Neovascularization, Pathologic
1
2004
285
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2004
552
0.010
 Why?
Immunohistochemistry
1
2004
1713
0.010
 Why?
Hypoxia
1
2004
1197
0.010
 Why?
Pollyea's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (484) concept(s)
_
Co-Authors Expand Description
See all (73) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)